Antonio Ceriello is an expert in Endocrinology at MultiMedica (Italy). As of October 2026, ScienceLeadR ranks Antonio Ceriello in the top 1% of experts worldwide for Hyperglycemia, Diabetes Complications and Diabetes Mellitus. Antonio Ceriello has authored 552 publications, the most recent in 2026, and is an investigator in 11 clinical trials, 1 of them ongoing. SLR score: 2,072 (community average: 125). How the SLR is computed.

LeadR Profile

Antonio Ceriello MultiMedica Italy
2 072 ScienceLeadR Reputation 2072
Network Map

Endocrinology

Subspecialties: Cardiology - Public Health - Biochemistry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1998 - 2026

Source: PubMed

MultiMedica

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Micro- and nano-plastics in the coronary circulation and air pollution exposure in ischaemic heart disease presentation.
PMID 42447841 — heart diseases, blood, polymers, air pollution, heart, arteries, coronary circulation, cardiology, air, st elevation myocardial infarction, environmental pollution, smoking, plastics
Eur Heart J Top journal20266
Smoking cessation and harm reduction in type 2 diabetes: development of practical recommendations from the DiaSmokeFree Working Group.
PMID 42645731 — diabetes mellitus, internal medicine, multiple chronic conditions, smoking cessation, smoking, diabetes mellitus, type 2, harm reduction
Intern Emerg Med20260
Microplastics in human lung tissue from autopsy samples collected in 1991 and 2024: a comparative post-mortem study.
PMID 42620939 — lung, polymers, microplastics, collagen, polyethylene, prevalence, tissues, plastics, autopsy
Lancet Reg Health Eur20260
Quality of care and clinical characteristics of adults with type 1 diabetes in Italy: insights from the 2025 AMD Annals initiative.
PMID 42462923 — diabetes mellitus, diabetes mellitus, type 1
Diabetes Res Clin Pract20260
Quality of care for migrant populations with type 2 diabetes mellitus in Italy: a retrospective analysis of data from the the Italian AMD (Associations of Medical Diabetologists) annals initiative.
PMID 42340410 — diabetes mellitus, therapeutics, diabetes mellitus, type 2
Acta Diabetol20260

Clinical Studies 11

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

N/A 4
Phase 3 3
Phase 4 3
Phase 1 1

By status:

Completed 9
Recruiting 1
Withdrawn 1

By type:

Interventional 8
Observational 3

By Monocentric/Multicentric:

monocentric 5
multicentric2to4 0
multicentric5to9 1
multicentricup10 5

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
GLP 1RAs) and SGLT2is Combination Therapy and MACEs in Patients With Type 2 Diabetes
NCT06017544 — diabetes mellitus, glucagon-like peptide 1, sodium-glucose transport proteins, mortality, glucagon-like peptide-1 receptor, myocardial infarction, glucagon, therapeutics, glucagon-like peptides, diabetes mellitus, type 2
N/ARecruiting2021

LeadR Networks

Main global connection map